Poliovirus spreads primarily through the fecal-oral route, passing from an infected person’s intestinal tract to another person’s mouth, usually through contaminated water, food, or hands. What makes polio particularly difficult to stamp out is that the vast majority of infections produce no paralysis at all, meaning the virus can circulate silently through a community for months while only a tiny fraction of those infected ever show the symptoms most people associate with the disease.
How Most People Get Infected
Poliovirus is swallowed, not inhaled, in the vast majority of transmission events. Once the virus reaches the gut, it replicates in the cells lining the intestines and is shed in large quantities in stool. From there, it contaminates hands, surfaces, and especially water supplies in places with inadequate sanitation. Another person ingests the virus, and the cycle repeats. This fecal-oral loop is the engine that drove the massive epidemics of the twentieth century and continues to sustain the virus in its last remaining strongholds.
A small body of research has questioned whether the respiratory route might play a larger role than the consensus view suggests. A 2024 paper argued on epidemiological grounds that available studies and observations support respiratory transmission rather than fecal-oral spread.1Infectious Diseases. The respiratory route of transmission of virulent polioviruses This remains a minority position. The global eradication strategy, built around oral vaccination and sanitation, has reduced wild poliovirus cases by more than 99%, which is hard to explain if fecal-oral transmission were irrelevant. Still, it is worth noting that the relative contribution of respiratory spread in certain settings is not fully settled.
Why Most Infections Are Invisible
Poliovirus is sometimes called an iceberg pathogen. The paralysis that defines the disease in the public imagination is actually its rarest outcome. In the pre-vaccine era, roughly 0.5% of infected individuals developed paralytic poliomyelitis.2PubMed Central. Innate host barriers to viral trafficking and population diversity: lessons learned from poliovirus The rates differ by serotype: about one in 200 for type 1, one in 1,000 for type 3, and one in 2,000 for type 2.3PubMed Central. Another look at silent circulation of poliovirus in small populations The remaining cases either produce no symptoms at all or cause a brief flu-like illness that resolves without anyone suspecting polio.
This lopsided ratio creates a surveillance nightmare. Hundreds or even thousands of infections can occur between successive paralytic cases, a pattern researchers call silent circulation.3PubMed Central. Another look at silent circulation of poliovirus in small populations A community can harbor active transmission for months before a single child turns up with a floppy limb. By the time a paralytic case is identified, the virus has already spread far beyond the index patient.
How the Virus Reaches the Nervous System
For the small fraction of infected people who do develop paralysis, the critical event is the virus leaving the gut and entering the bloodstream. Circulating poliovirus can cross the blood-brain barrier, the protective lining that normally keeps pathogens out of the brain and spinal cord. Research on human brain microvascular endothelial cells, an in vitro model of the blood-brain barrier, has shown that poliovirus enters these cells through a receptor-triggered signaling process.4PubMed Central. Poliovirus entry into human brain microvascular cells requires receptor-induced activation of SHP-2 Once inside the central nervous system, the virus targets motor neurons in the spinal cord and brainstem, destroying them and causing the muscle weakness or paralysis that defines poliomyelitis.
There is also a second route into the nervous system. Poliovirus can travel along peripheral nerves via retrograde axonal transport, essentially hitching a ride backward along nerve fibers from muscle tissue to the spinal cord.5PubMed Central. Poliovirus trafficking toward central nervous system via human poliovirus receptor-dependent and -independent pathway Animal studies have demonstrated that intravenous poliovirus can reach the central nervous system at a fairly high rate, even independently of the specific poliovirus receptor, suggesting the existence of a dedicated delivery mechanism.6PubMed. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor
Why Muscle Injuries Raise the Risk
An old clinical observation, confirmed by laboratory work, is that intramuscular injections given during or just before a poliovirus infection increase the risk of paralysis in the injected limb. This phenomenon, known as provocation poliomyelitis, occurs because skeletal muscle injury triggers retrograde axonal transport of poliovirus, pulling the virus from the injured tissue back along the nerve toward the spinal cord and accelerating its invasion of motor neurons.7PubMed Central. Mechanism of injury-provoked poliomyelitis During polio outbreaks in the mid-twentieth century, doctors noticed that children who had recently received injections of antibiotics or other vaccines were more likely to develop paralysis in the injected arm or leg. The practical takeaway, still relevant in endemic areas, is that unnecessary intramuscular injections should be avoided during active poliovirus circulation.
How Long Someone Sheds the Virus
An infected person can spread poliovirus before they feel sick, during illness, and for weeks afterward. In previously unvaccinated children, wild poliovirus is shed in stool for roughly three to four weeks after infection.8PubMed. Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature The virus can also be present in throat secretions during the first week or two, though fecal shedding lasts longer and is thought to be the main driver of transmission.
Vaccination shortens this window. Children who had received inactivated poliovirus vaccine shed less virus and for a shorter period than unvaccinated children. Studies comparing the two groups have found a roughly 63% to 91% reduction in the amount of virus shed in stool after vaccination with the inactivated vaccine, even though the vaccine does not fully prevent intestinal infection.9PLoS Pathogens. Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus Challenge Oral vaccine, by contrast, induces stronger mucosal immunity in the gut and is more effective at blocking intestinal infection altogether, which is one reason it has been the workhorse of the eradication campaign.
The Virus in the Environment
Poliovirus is remarkably durable outside the human body, especially in water. Studies of enteric viruses in freshwater have found inactivation rates of less than one log (a tenfold reduction) per day across tap water, river water, and groundwater, with groundwater showing the slowest decay.10FEMS Microbiology Reviews. Survival of human enteric viruses in the environment and food That means poliovirus can remain infectious in freshwater sources for days to weeks, depending on temperature and the type of water body. Experiments on poliovirus persistence in waste-impacted water and sediment have confirmed that temperature and the physical matrix are the strongest predictors of how fast the virus decays, with colder conditions extending survival substantially.11PLoS ONE. Persistence of poliovirus types 2 and 3 in waste-impacted water and sediment
This environmental hardiness is precisely why contaminated water has been such an effective vehicle for polio transmission in areas with poor sanitation. It also makes the environment useful for surveillance, as described below.
Tracking an Invisible Virus Through Sewage
Because so few infections produce paralysis, waiting for paralytic cases to appear is a slow way to detect poliovirus circulation. Environmental surveillance fills that gap by testing sewage and wastewater for poliovirus directly.12PubMed Central. Environmental surveillance for polioviruses in the Global Polio Eradication Initiative A single sewage sample can reveal virus being shed by infected individuals within the catchment area long before any clinical case is recognized.
Researchers have developed quantitative models linking the amount of poliovirus in sewage to the number of infected people in the contributing population. Work drawing on data from more than 63,000 people established a dose-dependent relationship between shedders and the concentration of poliovirus in sewage samples, allowing public health teams to estimate how many people are infected from environmental data alone.13PubMed. Estimation of polio infection prevalence from environmental surveillance data This approach proved its value in London in 2022, when enhanced environmental surveillance detected sustained circulation of type 2 poliovirus in sewage over several months. The early warning allowed authorities to mount a targeted vaccination campaign for children aged one to nine before any paralytic cases occurred.14PubMed Central. Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance
In parallel, clinical surveillance relies on the detection of acute flaccid paralysis, which remains the gold standard for identifying individual polio cases. Health systems worldwide are expected to investigate every case of sudden limb weakness in children under 15 and test stool samples for poliovirus.15PubMed Central. A review on health system-based surveillance for acute flaccid paralysis: technological advancements, challenges, and outlooks The two surveillance streams complement each other: sewage testing catches the silent spread, and clinical surveillance identifies the cases that confirm it.
The Vaccine-Derived Poliovirus Problem
The oral polio vaccine uses live but weakened strains of all three poliovirus types. It is cheap, easy to administer, and induces strong gut immunity, making it ideal for mass campaigns. But the weakened vaccine virus replicates in the intestine and is shed in stool, just like wild poliovirus. In rare circumstances, the shed vaccine virus can mutate back toward a more dangerous form, a process that can begin within days to weeks after vaccination.16PubMed Central. Sabin Vaccine Reversion in the Field: a Comprehensive Analysis of Sabin-Like Poliovirus Isolates in Nigeria
When these reverted strains circulate in under-vaccinated communities, they can cause outbreaks of paralysis indistinguishable from wild polio. Analysis of one such evolved isolate showed it was a recombinant that had been diverging from its vaccine ancestor for roughly two years before causing illness, demonstrating that these strains can circulate silently for extended periods while accumulating mutations that increase their ability to cause disease.17PubMed Central. Long-term circulation of vaccine-derived poliovirus that causes paralytic disease
To address this risk, a next-generation oral vaccine, novel oral poliovirus vaccine type 2 (nOPV2), was developed with genetic modifications designed to make reversion far less likely. The World Health Organization issued an Emergency Use Listing for nOPV2 in November 2020, and it has since been deployed in outbreak responses across multiple countries.18PubMed Central. Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience Clinical trial data showed that the shed virus from nOPV2 recipients had dramatically reduced odds of causing paralysis in mouse models compared to the traditional vaccine strain, with an adjusted odds ratio of 0.007.19The Lancet. Genetic and phenotypic stability of type 2 novel oral poliovirus vaccine in infants: a secondary analysis of two clinical trials That is a substantial improvement in genetic stability, though the vaccine is still being monitored closely in real-world use.
The Global Switch from Trivalent to Bivalent Oral Vaccine
Wild poliovirus type 2 was declared eradicated in 2015, and type 3 was declared eradicated in 2019, leaving only type 1 circulating in the wild. Because the old oral vaccine contained all three types, continued use of the type 2 component was creating more vaccine-derived outbreaks than the wild virus it was meant to prevent. In April and May of 2016, 36 countries in the Americas alone participated in a globally coordinated switch from the trivalent oral vaccine to a bivalent version that dropped the type 2 component.20Journal of Infectious Diseases. Systematization of the Introduction of IPV and Switch from tOPV to bOPV in the Americas Countries simultaneously introduced at least one dose of inactivated poliovirus vaccine into their routine schedules to maintain some type 2 protection. This was one of the largest coordinated vaccine program changes in history, and its success depended on tight synchronization to avoid leaving gaps in population immunity.
Immunodeficient Long-Term Excretors
Most people clear poliovirus from their bodies within weeks. But individuals with certain primary immunodeficiencies affecting B-cell function may be unable to clear the vaccine virus at all after receiving oral polio vaccine or coming in contact with a vaccinated person. These individuals can shed poliovirus continuously for months or years, and the virus evolves during that prolonged replication, potentially becoming more dangerous over time.21PubMed Central. Immunodeficiency-Related Vaccine-Derived Poliovirus (iVDPV) Infections: A Review of Epidemiology and Progress in Detection and Management The estimated risk of paralytic polio for these immunodeficient individuals is about 3,000-fold higher than for people with healthy immune systems.
Two children in the United Kingdom were identified as shedding vaccine-derived poliovirus for prolonged periods, illustrating how these cases can serve as a source of cryptic transmission with the potential to cause neurological disease in contacts.22Nature Communications. Asymptomatic immunodeficiency-associated vaccine-derived poliovirus infections in two UK children For the endgame of polio eradication, these long-term excretors represent one of the trickiest loose ends. Even after wild poliovirus is gone and oral vaccine use stops worldwide, any remaining immunodeficient excretors could theoretically reintroduce poliovirus into communities with waning immunity. Identifying and managing these individuals is an active area of public health work.
Who Spreads Polio and Where It Persists
Children under five have historically been considered the primary transmitters of poliovirus, and they are the focus of vaccination campaigns. But the role of older children and adults varies by setting. In the Republic of Congo, modeling of an outbreak estimated a reproductive number of 1.85 among older children and adults, suggesting they were contributing meaningfully to transmission, likely reflecting sanitary and socioeconomic conditions that allowed efficient person-to-person spread across age groups.23PubMed Central. The role of older children and adults in wild poliovirus transmission
As of the mid-2020s, wild poliovirus type 1 remains endemic in only Afghanistan and Pakistan. Spatial analysis of persistent transmission in those countries has identified three factors that independently increase the odds of poliovirus detection in a given district: armed conflict, food insecurity, and warmer temperatures during the wettest quarter of the year.24PLOS Global Public Health. Spatial analysis of genetic clusters and epidemiologic factors related to wild poliovirus type 1 persistence in Afghanistan and Pakistan Each additional conflict event in a district raised the probability of detection by about 2.4%, and each level increase in food insecurity raised the odds by over 50%. These findings underscore that polio’s last reservoirs are sustained not by biological mystery but by the practical difficulty of vaccinating children in areas defined by instability and poverty. The virus exploits the same gaps that every other public health intervention struggles with, and closing those gaps is ultimately what will determine whether eradication succeeds.